戻る
Infant Bacterial Therapeutics AB (publ) (IFTBF)価格
IFTBF 株価推移チャート
IFTBF 収入
Infant Bacterial Therapeutics AB (publ)
$5.47
14.43%
$0.68
終値： Jan 16, 16:00:00 GMT-5
$5.47
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
Earnings FAQ
IFTBFの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Infant Bacterial Therapeutics AB (publ) IFTBFの前四半期の収益はどうでしたか？
Infant Bacterial Therapeutics AB (publ)の収益見積もりはいくらですか？
Infant Bacterial Therapeutics AB (publ)の収益品質スコアはどれくらいですか？
Infant Bacterial Therapeutics AB (publ)はいつ収益を報告しますか？
Infant Bacterial Therapeutics AB (publ)の予想収益はいくらですか？
Infant Bacterial Therapeutics AB (publ)は収益予想を上回りましたか？
主要データ
前終値
$4.78
始値
$5.47
当日レンジ
$5.47 - $5.47
52週レンジ
$4.78 - $8.2
取引高
--
平均取引高
1.0K
1株当たり利益(TTM)
--
配当利回り
--
時価総額
--
INFANT BACTERIAL THERAPEUTICS Aとは何ですか？
Infant Bacterial Therapeutics AB is a clinical stage pharmaceutical company, which engages in the development of drugs for the treatment of rare diseases affecting premature infants. The company is headquartered in Stockholm, Stockholm and currently employs 10 full-time employees. The company went IPO on 2016-03-29. The firm develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of necrotizing enterocolitis (NEC), a fatal disease that affects premature infants.